Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome

NCT03383107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2022-08-12

No results posted yet for this study

Summary

Exposure to radiation can impact immune cells that are present in the blood, such as lymphocytes. It is hypothesized that larger radiation fields and/or longer courses of radiation, result in greater decrease in immune cells. To test this hypothesis, investigators will take blood samples from subjects undergoing two different standard of care radiation regimens for prostate cancer, and subjects undergoing two different standard of care regimens for breast cancer.

Conditions

Sponsors & Collaborators

  • Varian Medical Systems

    collaborator INDUSTRY
  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Silvia Formenti, M.D. · Weill Cornell Medicine - New York Presbyterian Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-22
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03383107 on ClinicalTrials.gov